Physician profile
Anna E Bortnick
NPI 1346391869
$3,953.43
in general payments reported to CMS, 2019-2025
18 companies · $760 in 2025
The $760 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2021: $577 · 2022: $936 · 2023: $977 · 2024: $438 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,636 · Travel and Lodging: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,636.13 |
| Travel and Lodging | $537.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $830.51 | 2019-2025 | Watchman Flx, Synergy |
| Medtronic, INC. | $538.52 | 2021-2025 | Ffrangio, Symplicity G3 |
| Getinge USA Sales, LLC | $537.80 | 2023 | Vasoview Hemopro 2 |
| Cardiovascular Systems INC. | $391.63 | 2021-2022 | |
| Abiomed | $370.45 | 2024-2025 | Impella |
| Abbott Laboratories | $306.51 | 2021-2024 | Optis, Ultreon |
| Inari Medical, INC. | $199.06 | 2022 | |
| Philips North America LLC | $167.46 | 2019-2025 | Angiosculpt Cv Rx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.78 | 2022-2025 | Lifevest |
| Esperion Therapeutics, INC. | $136.55 | 2024 | Nexletol, Nexlizet |
| Livanova USA, INC. | $133.44 | 2023 | Lifesparc |
| Spectrawave, INC | $103.95 | 2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Amgen INC. | $42.99 | 2022 | |
| Siemens Medical Solutions USA, INC. | $28.10 | 2025 | Automated Blood Coagulation Analyzer Cs-2500 |
| Stryker Corporation | $23.68 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bortnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.